HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qiang Xia Selected Research

Punctures

1/2012Mitochondrial nitric oxide synthase participates in septic shock myocardial depression by nitric oxide overproduction and mitochondrial permeability transition pore opening.
11/2010[Hemodynamics and aortic tension induced by two septic shock models in rats].
8/2008[Effect of nitric oxide synthase inhibitors on the changes of hemodynamic parameters and aortic tension induced by septic shock in rats].
5/2007[The alterations of nitric oxide synthase activity of ventricular cardiac muscle of rats in two septic shock models].
1/2005The relationship of ventricular dynamics and mitochondrial nitric oxide synthase activity in septic shock models.
12/2003[NO/cGMP signal pathway involved in the disturbance of calcium homeostasis in vascular smooth muscle during the late phase of sepsis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qiang Xia Research Topics

Disease

69Neoplasms (Cancer)
04/2024 - 08/2004
65Hepatocellular Carcinoma (Hepatoma)
01/2024 - 12/2007
52Ischemia
01/2022 - 01/2002
49Reperfusion Injury
09/2023 - 01/2002
26Infections
04/2024 - 03/2010
22Liver Diseases (Liver Disease)
04/2024 - 09/2013
21Infarction (Infarctions)
06/2013 - 01/2002
18Liver Neoplasms (Liver Cancer)
12/2023 - 07/2012
15Inflammation (Inflammations)
04/2024 - 01/2010
15Neoplasm Metastasis (Metastasis)
12/2023 - 08/2008
14Carcinogenesis
12/2023 - 08/2004
13Hypoxia (Hypoxemia)
10/2023 - 01/2003
12Biliary Atresia
01/2024 - 06/2012
12Cholangiocarcinoma
01/2021 - 11/2017
11Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 11/2010
9Myocardial Ischemia (Ischemic Heart Diseases)
03/2014 - 01/2002
8Hepatitis B
03/2024 - 11/2009
8Necrosis
11/2023 - 04/2011
8End Stage Liver Disease
07/2022 - 11/2009
8Myocardial Infarction
07/2017 - 01/2005
8Brain Ischemia (Cerebral Ischemia)
01/2013 - 05/2006
7Lymphatic Metastasis
12/2023 - 07/2016
7Carcinoma (Carcinomatosis)
08/2023 - 08/2004
7Cardiac Arrhythmias (Arrythmia)
02/2009 - 01/2002
6Hemorrhage
05/2023 - 08/2010
5COVID-19
03/2024 - 12/2020
5Fibrosis (Cirrhosis)
11/2022 - 01/2016
5HIV Infections (HIV Infection)
03/2022 - 03/2013
5Acquired Immunodeficiency Syndrome (AIDS)
01/2019 - 09/2014
5Heart Failure
08/2016 - 01/2005
5Septic Shock (Toxic Shock Syndrome)
01/2012 - 01/2005
4Breast Neoplasms (Breast Cancer)
12/2023 - 08/2004
4Acute Liver Failure (Fulminant Hepatic Failure)
12/2023 - 05/2014
4Bites and Stings (Sting)
12/2023 - 01/2021
4Mitochondrial Diseases (Mitochondrial Disease)
12/2023 - 10/2017
4Body Weight (Weight, Body)
10/2023 - 11/2011
4Hypertension (High Blood Pressure)
01/2021 - 07/2007
4Bacterial Infections (Bacterial Infection)
01/2020 - 12/2011
3Niemann-Pick Diseases (Niemann Pick Disease)
11/2023 - 01/2019

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
12/2023 - 01/2003
16L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2013 - 05/2004
15Biomarkers (Surrogate Marker)IBA
09/2023 - 06/2012
11Mitochondrial Permeability Transition PoreIBA
03/2014 - 01/2005
10KATP ChannelsIBA
12/2016 - 01/2004
9DNA (Deoxyribonucleic Acid)IBA
12/2023 - 08/2013
9EnzymesIBA
06/2023 - 01/2002
9Adenosine Triphosphate (ATP)IBA
02/2021 - 06/2003
9mitochondrial K(ATP) channelIBA
11/2010 - 06/2003
9FormazansIBA
05/2008 - 01/2005
8Messenger RNA (mRNA)IBA
01/2020 - 01/2003
8kappa Opioid Receptors (kappa Opioid Receptor)IBA
08/2010 - 05/2004
7RNA (Ribonucleic Acid)IBA
01/2024 - 12/2014
7InterferonsIBA
12/2023 - 01/2014
7Aflatoxin B1 (Aflatoxin B)IBA
06/2018 - 07/2013
7norbinaltorphimineIBA
08/2010 - 05/2004
7(trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamideIBA
08/2010 - 01/2003
7AtractylosideIBA
11/2009 - 01/2005
6Phosphotransferases (Kinase)IBA
12/2023 - 09/2007
6alpha-Fetoproteins (alpha-Fetoprotein)IBA
12/2023 - 10/2009
6MicroRNAs (MicroRNA)IBA
01/2023 - 01/2013
6Tacrolimus (Prograf)FDA LinkGeneric
11/2022 - 08/2004
6Small Interfering RNA (siRNA)IBA
01/2022 - 08/2008
6LipopolysaccharidesIBA
01/2022 - 01/2005
6Reactive Oxygen Species (Oxygen Radicals)IBA
10/2017 - 06/2003
6AflatoxinsIBA
02/2016 - 01/2013
65-hydroxydecanoic acidIBA
11/2010 - 01/2004
6puerarinIBA
11/2010 - 03/2004
6Neuroprotective AgentsIBA
04/2010 - 05/2006
5AntioxidantsIBA
01/2022 - 02/2005
5Glucose (Dextrose)FDA LinkGeneric
05/2015 - 05/2005
5Interleukin-2 (IL2)IBA
12/2006 - 01/2003
5Diazoxide (Hyperstat)FDA Link
07/2006 - 06/2003
5CalciumIBA
05/2004 - 01/2003
4VaccinesIBA
03/2024 - 01/2021
4CytokinesIBA
01/2024 - 11/2010
4Acetaminophen (Paracetamol)FDA LinkGeneric
12/2023 - 01/2017
4Anti-Bacterial Agents (Antibiotics)IBA
09/2023 - 01/2020
4Indicators and Reagents (Reagents)IBA
01/2022 - 04/2015
4CateninsIBA
01/2022 - 11/2014
4Oxygen (Dioxygen)IBA
01/2021 - 05/2005
4Antiviral Agents (Antivirals)IBA
08/2020 - 08/2014
4IntegrinsIBA
01/2018 - 08/2014
4Superoxide DismutaseIBA
06/2013 - 01/2002
4triphenyltetrazoliumIBA
06/2013 - 01/2005
4Nitric Oxide Synthase (NO Synthase)IBA
01/2012 - 01/2005
4NG-Nitroarginine Methyl Ester (L-NAME)IBA
01/2012 - 02/2005
41- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
02/2010 - 02/2005
4SpermineIBA
07/2009 - 05/2006
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2006 - 06/2003
4NS 1619IBA
12/2005 - 01/2005

Therapy/Procedure

83Liver Transplantation
04/2024 - 08/2008
28Therapeutics
12/2023 - 02/2003
19Transplantation
09/2023 - 08/2004
14Ligation
01/2012 - 12/2002
9Hepatectomy
04/2024 - 12/2008
6Punctures
01/2012 - 12/2003
6Ischemic Postconditioning
08/2009 - 01/2007
5Drug Therapy (Chemotherapy)
01/2023 - 10/2009
4Immunotherapy
01/2024 - 01/2014
3Organ Transplantation
09/2023 - 08/2020